CIK 0001829635 · <br>Emerging growth company
Transcode Therapeutics, Inc.
Sign in to watch- Ticker
- RNAZ
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 811065054
- Phone
- 857-301-6857
- Business address
- 6 LIBERTY SQUARE, #2382, BOSTON, MA, 02109
- 8-K Event Shareholder vote results · Other events
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- DEF 14A Proxy Proxy Statement
- 8-K Event Other events
- PRE 14A Proxy Proxy Statement (Preliminary)
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- D Other Notice of Sales of Unregistered Securities
- S-1 Offering Registration Statement
- 8-K Event Material agreement · Unregistered share sale · Regulation FD disclosure · Other events
- 8-K Event Shareholder rights changed · Bylaws or fiscal year change · Regulation FD disclosure
- 8-K Event Shareholder vote results
- 10-Q Report Quarterly Report
- DEFA14A Proxy Proxy Materials
- SC 13G/A Stake Amended Statement of Ownership
- DEFA14A Proxy Proxy Materials
- 8-K Event Delisting notice
- DEF 14A Proxy Proxy Statement
- PRE 14A Proxy Proxy Statement (Preliminary)
Page 6 of 17 · 324 filings